Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Therapies for Long COVID in non-hospitalised individuals
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{stub}} The '''TLC Study''' or '''Therapies for Long COVID in non-hospitalised individuals''': From symptoms, patient-reported outcomes and immunology to targeted therapies.<ref name="NIHRminutes26896">{{Cite web|url=https://www.nihr.ac.uk/documents/research-into-the-longer-term-effects-of-covid-19-in-non-hospitalised-individuals-funding-panel-meeting-minutes/26896 | title = Research into the longer term effects of COVID-19 in non-hospitalised individuals- Funding Panel Meeting Minutes|website=nihr.ac.uk|access-date=2021-03-01}}</ref><ref name="UKRI-18.5m">{{Cite web|url=https://www.ukri.org/news/18-5-million-to-tackle-long-covid-in-the-community/ | title = £18.5 million to tackle ‘Long-COVID’ in the community – UKRI|website=ukri.org|access-date=2021-03-01}}</ref> ==Funding== £2.2m over two years. Funded by the UK [[National Institute for Health Research]] (NIHR) and [[UK Research and Innovation]].<ref name="BHP-18Feb2021">{{Cite news | date = Feb 18, 2021 | url = https://www.birminghamhealthpartners.co.uk/2-2m-research-project-aims-to-improve-treatment-and-understanding-of-long-covid/ | title =£2.2m research project aims to improve treatment and understanding of Long COVID|publisher =Birmingham Health Partners}}</ref> ==Results== None published yet. ==Criticism== ==Investigators== * Shamil Haroon, University of Birmingham - Principal Investigator * Melanie Calvert, University of Birmingham - Co-Principal Investigator<ref name="srm">{{Cite web|url=https://srmrc.nihr.ac.uk/staff/professor-mel-calvert/ | title = Professor Mel Calvert | last = | first = | authorlink = | date = 2019-07-30 | website = srmrc.nihr.ac.uk|language=en-GB|archive-url=|archive-date=|url-status=|access-date=2021-03-01}}</ref> Other researchers include Dr Krish Nirantharakumar, Dr Joht Singh Chandan, Dr Olalekan Lee Aiyegbusi, Professor Janet Lord, Professor David Wraith, Professor Alastair Denniston, Dr Sarah Hughes, Dr Louise Jackson, Dr Grace Turner, Dr Samantha Cruz Rivera, Dr Anuradhaa Subramanian, Professor Georgios Gkoutos, Professor Elizabeth Sapey, Professor Tom Marshall, Dr Christel McMullan, Professor Steven Marwaha, and COVID-19 survivor [[Gary Price]] who will also act as a co-investigator. It also includes Dr Puja Myles and Dr Tim Williams, of the [[Medicines and Healthcare products Regulatory Agency]] (MRHA), and Dr Elin Haf Davies, of Aparito Limited.<ref name="BHP-18Feb2021" /> ==Project partners== *[[LongCovidSOS]] *[[National Institute for Health and Care Excellence|NICE]] *the UK Coronavirus Immunology Consortium (UK-CIC) *[[PHOSP-COVID|Post-hospitalisation COVID-19 Study Consortium]] (PHOSP-COVID). ==News and articles == *Feb 18, 2921, [https://www.birminghamhealthpartners.co.uk/2-2m-research-project-aims-to-improve-treatment-and-understanding-of-long-covid/ £2.2m research project aims to improve treatment and understanding of Long COVID] - Birmingham Health Partners] == See also == * [[Long COVID]] ==Learn more == *[https://www.nihr.ac.uk/documents/research-into-the-longer-term-effects-of-covid-19-in-non-hospitalised-individuals-funding-panel-meeting-minutes/26896 Research into the longer term effects of COVID-19 in non-hospitalised individuals- Funding Panel Meeting Minutes] *[https://www.ukri.org/news/18-5-million-to-tackle-long-covid-in-the-community/ £18.5 million to tackle ‘Long-COVID’ in the community – UKRI] ==References == {{Reflist}} [[Category:Long COVID studies]]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Templates used on this page:
Template:Asbox
(
edit
)
Template:Cite news
(
edit
)
Template:Cite web
(
edit
)
Template:Full stop
(
edit
)
Template:Full stop character
(
edit
)
Template:GetFallback
(
edit
)
Template:Help improve text
(
edit
)
Template:LangSwitch
(
edit
)
Template:Main other
(
edit
)
Template:No fullstop
(
edit
)
Template:No fullstop/first
(
edit
)
Template:Reflist
(
edit
)
Template:Str endswith
(
edit
)
Template:Stub
(
view source
) (semi-protected)
Template:Stub text
(
edit
)
Template:Uselang
(
edit
)
Module:Arguments
(
edit
)
Module:Asbox
(
edit
)
Module:Buffer
(
edit
)
Module:Check for unknown parameters
(
edit
)
Module:Citation/CS1
(
edit
)
Module:Citation/CS1/COinS
(
edit
)
Module:Citation/CS1/Configuration
(
edit
)
Module:Citation/CS1/Date validation
(
edit
)
Module:Citation/CS1/Identifiers
(
edit
)
Module:Citation/CS1/Utilities
(
edit
)
Module:Citation/CS1/Whitelist
(
edit
)
Module:Navbar
(
edit
)
Module:No globals
(
edit
)
Module:String
(
edit
)
This page is a member of 2 hidden categories:
Category:All stub articles
Category:Stub pages last edited in 2023
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs